Home

Search Abstracts

Browse Oral Sessions

Browse Poster Sessions

Session 139-Poster Abstracts Inflammatory Biomarkers, Immune Activation, and ART Tuesday, 2-4 pm; Poster Hall       836 Longitudinal Analysis of Microbial Translocation Markers in Patients on Efavirenz and Lopinavir/ritonavir-based ART Babilonia Barqasho*1, S Abdurahman1, P Nowak1,2, J Vesterbacka2, L-M Andersson3, J Svärd1, M Troseid4, M Gisslen3, and A Sönnerborg1,2 1Karolinska Inst, Stockholm, Sweden; 2Karolinska Univ Hosp, Stockholm, Sweden; 3Sahlgrenska Univ Hosp, Gothenburg, Sweden; and 4Oslo Univ Hosp, Norway       837 Association between Markers of Immune Activation, Inflammation, Coagulation, and Virologic Failure in ACTG A5262: A Single-arm Study of Darunavir/ritonavir Plus Raltegravir in Treatment-naïve HIV-1+ Patients Cara Wilson*1, R Matining2, J Eron3, L Zheng2, C Rinaldo4, M Lederman5, D Kuritzkes6, A Jennings7, P Kim8, and B Taiwo9 1Univ of Colorado Denver, Aurora, US; 2Statistical and Data Analysis Ctr, Harvard Sch of Publ Hlth, Boston, MA, US; 3Univ of North Carolina at Chapel Hill, US; 4Univ of Pittsburgh, PA, US; 5Case Western Reserve Univ, Cleveland, OH, US; 6Harvard Med Sch, Boston, MA, US; 7Frontier Sci and Tech Res Fndn, Amherst, NY, US; 8DAIDS, NIAID, NIH, Bethesda, MD, US; and 9Northwestern Univ, Chicago, IL, US       838 CVD Risk Markers in Patients Receiving Abacavir, Tenofovir, and Zidovudine: The Nucleoside Inflammation, Coagulation, and Endothelial Function (NICE) Study David Wohl*1, G Arnoczy1, C Fichtenbaum2, T Campbell3, B Taiwo4, C Hicks5, G McComsey6, S Koletar7, P Sax8, and J Stein9 1Univ of North Carolina at Chapel Hill, US; 2Univ of Cincinnati, OH, US; 3Univ of Colorado Denver, US; 4Northwestern Univ, Chicago, IL, US; 5Duke Univ, Durham, NC, US; 6Case Western Reserve Univ, Cleveland, OH, US; 7Ohio State Univ, Columbus, US; 8Harvard Med Sch, Boston, MA, US; and 9Univ of Wisconsin Sch of Med and Publ Hlth, Madison, US       839 Potential Atherogenic Biomarkers among HIV+ Women Initiating ART Christina Parrinello*1, A Landay2, H Hodis3, P Norris4, K Anastos1, P Tien4,5, X Xue1, L Benning6, R Tracy7, and R Kaplan1 1Albert Einstein Coll of Med, Bronx, NY, US; 2Rush Univ Med Ctr, Chicago, IL, US; 3Univ of Southern California, Los Angeles, US; 4Univ of California, San Francisco, US; 5San Francisco VAMC, CA, US; 6Johns Hopkins Univ Bloomberg Sch of Publ Hlth, Baltimore, MD, US; and 7Univ of Vermont Coll of Med, Burlington, US       840 Decrease in Inflammatory and Coagulation Biomarkers in HIV+ Patients after Switching from Enfuvirtide to Raltegravir: The Randomized ANRS 138 EASIER Trial Erika Silva*1, I Charreau2, B Gourmel1, S Mourah1, I Kalidi1, B Guillon2, N De Castro1, C François3, J Braun2, J-M Molina1, and the ANRS Easier Study Group 1Hosp St Louis, Paris, France; 2INSERM SC 10, Villejuif, France; and 3Hosp Rouen, France       841 Asymmetric Dimethylarginine Levels Are Associated with Elevated Pulmonary Artery Pressure in HIV+ Individuals Rushi Parikh*, R Scherzer, E Nitta, A Leone, C Donovan, J Morelli, S Deeks, P Ganz, J Martin, and P Hsue Univ of California, San Francisco, US